PATENTS
Application by Axcan Pharma Inc. for order prohibiting Minister of Health from issuing notice of compliance to Pharmascience Inc. for its version of Axcan’s drug Urso®— Dosage portion essential element of patent claim listed against Urso®—As such, patent invalid as claiming method of medical treatment—Application dismissed.
Axcan Pharma Inc. v. Pharmascience Inc. (T‑1005‑04, 2006 FC 527, Harrington J., order dated 26/4/06, 19 pp.)
You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.